PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer. Chabanon RM, Morel D, Eychenne T, Colmet-Daage L, et al. Cancer Res 2021;81:2888-2902.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chabanon RM, Morel D, Eychenne T, Colmet-Daage L, et al. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer. Cancer Res 2021;81:2888-2902.
PMID: 33888468